In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Alexandre Mebazaa
Speaker
Alexandre Mebazaa
Alexandre Mebazaa Alexandre Mebazaa

Hospital Lariboisiere, Paris (France)

Specialities : Acute Heart Failure , Chronic Heart Failure

60 presentations from this speaker

Challenges of pharmacotherapy in acute heart failure: diuretic resistance, inotropes and inodilators.

Event : ESC Congress 2020

  • Session : Facts and Controversies in Acute Heart Failure
  • Speaker : A Mebazaa (Paris,FR)

A practical approach to diuretic use in heart failure.

Event : Webinar 2019

  • Session : HFA Webinars 2019
  • Speaker : K Damman (Groningen,NL), A Mebazaa (Paris,FR), W Mullens (Genk,BE)

Case 1: when to suspect and treat ischemia in acute heart failure - Beyond troponin

Event : ESC Congress 2019

  • Session : Meet the Experts - Triggers of AHF
  • Speaker : A Mebazaa (Paris,FR)

Circulating dipeptidyl peptidase-3 is a myocardial depressant factor: Procizumab promptly and sustainably restored hemodynamics in heart failure

Event : ESC Congress 2019

  • Session : Late Breaking Basic and Translational Science - Acute Coronary Syndromes and Heart Failure
  • Speaker : A Mebazaa (Paris,FR)

Definition and clinical phenotypes.

Event : Heart Failure 2019

  • Session : Cardiogenic shock: recent advances and future perspectives
  • Speaker : A Mebazaa (Paris,FR)

Discussant review - GALACTIC

Event : ESC Congress 2019

  • Session : Hot Line Session 3
  • Speaker : A Mebazaa (Paris,FR)

Discussions, questions and answers

Event : ESC Congress 2019

  • Session : Heart failure treatment - Keeping the patient on the top of our mind
  • Speaker : JJV McMurray (Glasgow,GB), A Mebazaa (Paris,FR), J Januzzi (Boston,US)
  • Sponsored by Novartis Pharma AG

Faculty discussion - How heart failure biomarkers change clinical practice in the management of acute heart failure.

Event : Heart Failure 2019

  • Session : How heart failure biomarkers change clinical practice in the management of acute heart failure
  • Speaker : A Mebazaa (Paris,FR), HP Brunner-La Rocca (Maastricht,NL), H Gaggin (Boston,US), D Logeart (Paris,FR), R Troughton (Christchurch,NZ)
  • Sponsored by Roche Diagnostics

From classroom to clinic: sodium–glucose co-transporter 2 inhibitor evidence in practice.

Event : Heart Failure 2019

  • Session : Sodium–glucose co-transporter 2 inhibition and the heart: lessons from cardiovascular outcomes trials in Type 2 diabetes (EBAC Accredited)
  • Speaker : S Verma (Toronto,CA), M Cowie (London,GB), S Wiviott (Boston,US), A Mebazaa (Paris,FR)
  • Organised by the Sahlgrenska Academy, University of Gothenburg, Sweden, supported with an educational grant from AstraZeneca. Course Director: Professor Karl Swedberg

Key learnings and close

Event : ESC Congress 2019

  • Session : Heart failure treatment - Keeping the patient on the top of our mind
  • Speaker : A Mebazaa (Paris,FR)
  • Sponsored by Novartis Pharma AG

Mechanical support in acute heart failure.

Event : ESC Congress 2019

  • Session : Cutting edge heart failure treatment
  • Speaker : A Mebazaa (Paris,FR)

Q&A - Sodium–glucose co-transporter 2 inhibition and the heart: lessons from cardiovascular outcomes trials in Type 2 diabetes.

Event : Heart Failure 2019

  • Session : Sodium–glucose co-transporter 2 inhibition and the heart: lessons from cardiovascular outcomes trials in Type 2 diabetes (EBAC Accredited)
  • Speaker : S Verma (Toronto,CA), M Cowie (London,GB), A Mebazaa (Paris,FR), M Pfeffer (Boston,US)
  • Organised by the Sahlgrenska Academy, University of Gothenburg, Sweden, supported with an educational grant from AstraZeneca. Course Director: Professor Karl Swedberg

State of the Art - Novel and established diagnostic methods in acute heart failure

Event : ESC Congress 2019

  • Session : Comprehensive investigations in acute heart failure
  • Speaker : A Mebazaa (Paris,FR)

The road ahead in acute heart failure.

Event : Webinar 2019

  • Session : HFA Webinars 2019
  • Speaker : O Chioncel (Bucuresti,RO), A Mebazaa (Paris,FR), W Mullens (Genk,BE)

Welcome and introduction

Event : ESC Congress 2019

  • Session : Heart failure treatment - Keeping the patient on the top of our mind
  • Speaker : A Mebazaa (Paris,FR)
  • Sponsored by Novartis Pharma AG

Welcome and introductions - Sodium–glucose co-transporter 2 inhibition and the heart: lessons from cardiovascular outcomes trials in Type 2 diabetes.

Event : Heart Failure 2019

  • Session : Sodium–glucose co-transporter 2 inhibition and the heart: lessons from cardiovascular outcomes trials in Type 2 diabetes (EBAC Accredited)
  • Speaker : A Mebazaa (Paris,FR)
  • Organised by the Sahlgrenska Academy, University of Gothenburg, Sweden, supported with an educational grant from AstraZeneca. Course Director: Professor Karl Swedberg

Biomarkers to optimize heart failure therapy after discharge.

Event : ESC Congress 2018

  • Session : Biomarkers in cardiology
  • Speaker : A Mebazaa (Paris,FR)
  • Sponsored by Roche

Haemodynamic monitoring

Event : Heart Failure 2018

  • Session : Cardiogenic shock
  • Speaker : A Mebazaa (Paris,FR)

Mechanical support of the right ventricle.

Event : Acute Cardiovascular Care 2018

  • Session : To lyse or not to lyse the thrombus?
  • Speaker : A Mebazaa (Paris,FR)

Mechanisms of acute heart failure.

Event : Acute Cardiovascular Care 2018

  • Session : Acute heart failure: mechanisms and diagnosis
  • Speaker : A Mebazaa (Paris,FR)

Pre-discharge optimisation of pharmacological therapy in heart failure

Event : ESC Congress 2018

  • Session : Expert Advice - How to prevent readmissions in patients with acute heart failure
  • Speaker : A Mebazaa (Paris,FR)

Renal biomarkers

Event : Heart Failure 2018

  • Session : Biomarkers - Tips and tricks
  • Speaker : A Mebazaa (Paris,FR)

The golden hours of acute heart failure treatment

Event : ESC Congress 2018

  • Session : Expert Advice - Management of acute heart failure in the emergency room
  • Speaker : A Mebazaa (Paris,FR)

Acute heart failure in the emergency room.

Event : Heart Failure 2017

  • Session : Heart failure management: when the clinician needs advice
  • Speaker : A Mebazaa (Paris,FR)

Biomarkers.

Event : Heart Failure 2017

  • Session : The year's best papers on heart failure
  • Speaker : A Mebazaa (Paris,FR)

Cardiogenic shock - How to monitor the patient

Event : ESC Congress 2017

  • Session : Cardiogenic shock update
  • Speaker : A Mebazaa (Paris,FR)

Devices and multidisciplinary interventions in heart failure – New concepts

Event : ESC Congress 2017

  • Session : The future of heart failure therapy
  • Speaker : A Mebazaa (Paris,FR)
  • Heart Failure Association (ESC)

How to assess congestion in heart failure

Event : ESC Congress 2017

  • Session : How to tackle congestion in heart failure
  • Speaker : A Mebazaa (Paris,FR)

Improving outcomes in acute heart failure: quo vadis?

Event : Heart Failure 2017

  • Session : Advancing acute heart failure treatment – quo vadis?
  • Speaker : JJV McMurray (Glasgow,GB), A Mebazaa (Paris,FR), JR Teerlink (San Francisco,US)
  • Sponsored by Novartis

Inotropes: a double-edged sword.

Event : Heart Failure 2017

  • Session : Therapy of cardiogenic shock
  • Speaker : A Mebazaa (Paris,FR)

The role and the place of natriuretic peptides in the 2016 ESC Guidelines.

Event : ESC Congress 2017

  • Session : How N-terminal pro-brain natriuretic peptide (NT-proBNP) can help us all along heart failure patient journey: from guidelines to implementation in our daily practice
  • Speaker : A Mebazaa (Paris,FR)
  • Sponsored by Roche Diagnostics International

Vasodilators in acute heart failure: the beginning of the end.

Event : Heart Failure 2017

  • Session : Vasodilators in acute heart failure
  • Speaker : A Mebazaa (Paris,FR)

Welcome and introduction.

Event : Heart Failure 2017

  • Session : Advancing acute heart failure treatment – quo vadis?
  • Speaker : JJV McMurray (Glasgow,GB), A Mebazaa (Paris,FR)
  • Sponsored by Novartis

Welcome to Heart Failure 2017 & World Congress on Acute Heart Failure.

Event : Heart Failure 2017

  • Session : Inaugural Session
  • Speaker : A Mebazaa (Paris,FR)

Acute heart failure with preserved systolic function.

Event : Acute Cardiovascular Care 2016

  • Session : Update on acute heart failure
  • Speaker : A Mebazaa (Paris,FR)
  • Joint session with the Heart Failure Association of the ESC (HFA)

Adrenomedulin.

Event : Heart Failure 2016

  • Session : Biomarkers in heart failure: what's new?
  • Speaker : A Mebazaa (Paris,FR)

Cardiorenal syndrome and acute kidney injury.

Event : Acute Cardiovascular Care 2016

  • Session : Renal failure in cardiac intensive care
  • Speaker : A Mebazaa (Paris,FR)

Future direction for research in cardiogemic shock .

Event : ESC Congress 2016

  • Session : Cardiogenic shock
  • Speaker : A Mebazaa (Paris,FR)

Optimising AHF treatment to relieve symptoms, prevent organ damage and improve outcomes.

Event : Acute Cardiovascular Care 2016

  • Session : Rationale for addressing symptoms and organ injury in acute heart failure treatment
  • Speaker : A Mebazaa (Paris,FR)
  • Sponsored by Novartis

Practical recommendations

Event : Heart Failure 2016

  • Session : How to use inotropes in cardiogenic shock
  • Speaker : A Mebazaa (Paris,FR)

The patient with acute heart failure in intensive care unit - Take home message

Event : ESC Congress 2016

  • Session : The patient with acute heart failure in intensive care unit
  • Speaker : A Mebazaa (Paris,FR)

The role of natriuretic peptides in the diagnosis of acute heart failure.

Event : Acute Cardiovascular Care 2016

  • Session : The use of biomarkers in ACS and heart failure
  • Speaker : A Mebazaa (Paris,FR)

The use of the chest X-ray and biomarkers in patients presenting with acute dyspnea.

Event : Acute Cardiovascular Care 2016

  • Session : The patient with dyspnea in the emergency department
  • Speaker : A Mebazaa (Paris,FR)

Volume optimisation and vasoactives.

Event : Heart Failure 2016

  • Session : How to manage acute right ventricular failure
  • Speaker : A Mebazaa (Paris,FR)

Winners of the 2015 Heart Failure Awareness Days.

Event : Heart Failure 2016

  • Session : Inaugural Session
  • Speaker : A Mebazaa (Paris,FR)

Acute heart failure: addressing the unmet treatment needs.

Event : Heart Failure 2015

  • Session : The failing heart: a team approach to address unmet needs for better patient care
  • Speaker : A Mebazaa (Paris,FR)
  • Sponsored by Novartis Pharma

Acute right ventricular failure.

Event : Acute Cardiovascular Care 2015

  • Session : Acute heart failure in special situations
  • Speaker : A Mebazaa (Paris,FR)

Cardiohepatic syndrome.

Event : Acute Cardiovascular Care 2015

  • Session : Organ dysfunction in acute heart failure
  • Speaker : A Mebazaa (Paris,FR)

Congestion: ino- or dilator?

Event : Heart Failure 2015

  • Session : The patient perspective - Effects of levosimendan on hemodynamics and quality of life
  • Speaker : A Mebazaa (Paris,FR)
  • Sponsored by Orion Pharma

Discussion, questions and answers.

Event : Heart Failure 2015

  • Session : Ask the experts: your questions answered on HF management and multidisciplinary approaches
  • Speaker : JJV McMurray (Glasgow,GB), A Voors (Groningen,NL), A Mebazaa (Paris,FR), J Diez Martinez (Pamplona,ES), T McDonagh (London,GB), H Bueno (Madrid,ES), A Stromberg (Linkoping,SE)
  • Sponsored by Novartis Pharma

Tips & tricks on how to treat acute heart failure - Introduction to the session.

Event : ESC Congress 2015

  • Session : Tips & tricks on how to treat acute heart failure
  • Speaker : A Mebazaa (Paris,FR)

Use of adjuncts in AHF: potassium binders.

Event : Heart Failure 2015

  • Session : Acute heart failure: novel therapies on the horizon
  • Speaker : A Mebazaa (Paris,FR)

Vasodilator therapy in acute heart failure: evidence or non-evidence?

Event : Acute Cardiovascular Care 2015

  • Session : Innovations in acute heart failure
  • Speaker : A Mebazaa (Paris,FR)

What treatment algorithm.

Event : Heart Failure 2015

  • Session : Recommendations on pre-hospital and hospital management of acute heart failure
  • Speaker : A Mebazaa (Paris,FR)

Acute heart failure therapies.

Event : ESC Congress 2014

  • Session : The class effect myth: not all members of a class are created equal
  • Speaker : A Mebazaa (Paris,FR)

Limitations of current medical management.

Event : ESC Congress 2014

  • Session : The ongoing challenge of cardiogenic shock
  • Speaker : A Mebazaa (Paris,FR)

Heart-lung or lung-heart interactions, which are more important?

Event : ESC Congress 2013

  • Session : The heart and other organs
  • Speaker : A Mebazaa (Paris,FR)

Liver under pressure of heart failure.

Event : ESC Congress 2013

  • Session : Gut and liver metabolism in heart failure: why bother?
  • Speaker : A Mebazaa (Paris,FR)

Medical management.

Event : ESC Congress 2013

  • Session : Management of cardiogenic shock
  • Speaker : A Mebazaa (Paris,FR)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are